As­traZeneca's ‘ra­diosen­si­tiz­er’ may en­hance ef­fi­ca­cy of ra­di­a­tion for dead­ly brain can­cer: #AACR24

Re­searchers are test­ing an ex­per­i­men­tal drug de­vel­oped by As­traZeneca with ra­di­a­tion to see if pair­ing the treat­ments will boost ra­di­a­tion’s ef­fi­ca­cy in glioblas­toma, a no­to­ri­ous­ly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER